A. Langer

565 total citations
18 papers, 192 citations indexed

About

A. Langer is a scholar working on Neurology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Langer has authored 18 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Langer's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Balance, Gait, and Falls Prevention (3 papers) and Stroke Rehabilitation and Recovery (2 papers). A. Langer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Balance, Gait, and Falls Prevention (3 papers) and Stroke Rehabilitation and Recovery (2 papers). A. Langer collaborates with scholars based in Austria, Australia and Germany. A. Langer's co-authors include Heidemarie Zach, Rochus Pokan, Walter Maetzler, Peter Dabnichki, Georg Gelbenegger, Shuhao Zhu, Ingrid Pabinger, Paul W. Armstrong, James C. Gilbert and Stefan Greisenegger and has published in prestigious journals such as Scientific Reports, Clinical Rehabilitation and Journal of NeuroEngineering and Rehabilitation.

In The Last Decade

A. Langer

18 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Langer Austria 7 51 36 29 26 21 18 192
Charles Joussain France 10 61 1.2× 53 1.5× 39 1.3× 29 1.1× 21 1.0× 41 263
Wan-Chun Liao Taiwan 12 27 0.5× 21 0.6× 45 1.6× 33 1.3× 54 2.6× 20 311
Christina‐Anastasia Rapidi Greece 10 46 0.9× 80 2.2× 11 0.4× 35 1.3× 32 1.5× 26 212
Susanna Lavezzi Italy 7 68 1.3× 28 0.8× 15 0.5× 50 1.9× 12 0.6× 15 260
Halil Önder Türkiye 8 128 2.5× 68 1.9× 9 0.3× 8 0.3× 16 0.8× 90 243
Gyu Sik Kim South Korea 9 74 1.5× 26 0.7× 56 1.9× 43 1.7× 18 0.9× 19 271
Masafumi Nakagawa Japan 10 29 0.6× 26 0.7× 8 0.3× 14 0.5× 102 4.9× 34 254
Jørgen Jørgensen Denmark 8 27 0.5× 36 1.0× 51 1.8× 105 4.0× 15 0.7× 25 292
Heeyoune Jung South Korea 9 66 1.3× 54 1.5× 4 0.1× 48 1.8× 26 1.2× 16 250

Countries citing papers authored by A. Langer

Since Specialization
Citations

This map shows the geographic impact of A. Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Langer more than expected).

Fields of papers citing papers by A. Langer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Langer. The network helps show where A. Langer may publish in the future.

Co-authorship network of co-authors of A. Langer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Langer. A scholar is included among the top collaborators of A. Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Langer. A. Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Langer, A., Clint Hansen, Dominik von Roth, et al.. (2024). Vertical locomotion improves horizontal locomotion: effects of climbing on gait and other mobility aspects in Parkinson’s disease. A secondary analysis from a randomized controlled trial. Journal of NeuroEngineering and Rehabilitation. 21(1). 63–63. 3 indexed citations
2.
Langer, A., Dominik von Roth, Rochus Pokan, et al.. (2023). Climb up! Head up! Climbing improves posture in Parkinson's disease. A secondary analysis from a randomized controlled trial. Clinical Rehabilitation. 37(11). 1492–1500. 3 indexed citations
3.
Langer, A., Rejko Krüger, Daniel Weiß, et al.. (2022). Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation. Neuromodulation Technology at the Neural Interface. 26(2). 364–373. 3 indexed citations
4.
Dabnichki, Peter, et al.. (2022). The therapeutic effects of climbing: A systematic review and meta‐analysis. PM&R. 15(9). 1194–1209. 18 indexed citations
5.
Sommer, Peter, Alexandra Posekany, Wolfgang Serles, et al.. (2022). Thrombectomy in basilar artery occlusion. International Journal of Stroke. 17(9). 1006–1012. 4 indexed citations
6.
Langer, A., Rochus Pokan, Peter Dabnichki, et al.. (2021). A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson’s disease. npj Parkinson s Disease. 7(1). 49–49. 11 indexed citations
7.
Langer, A., et al.. (2021). How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review. npj Parkinson s Disease. 7(1). 25–25. 56 indexed citations
8.
Greisenegger, Stefan, A. Langer, Georg Gelbenegger, et al.. (2021). The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients. Scientific Reports. 11(1). 3092–3092. 25 indexed citations
9.
Khanna, Dinesh, Daniel E. Furst, Nicholas S. Hill, et al.. (2015). Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative.. Clinical and Experimental Rheumatology. 32(6 Suppl 86). S–21. 3 indexed citations
10.
Goodman, Shaun G., A. Langer, Kim A. Connelly, et al.. (2015). BLOOD PRESSURE MANAGEMENT IN PATIENTS WITH DIABETES: INSIGHTS FROM THE DIABETES MELLITUS STATUS IN CANADA (DM-SCAN) SURVEY. Canadian Journal of Cardiology. 31(10). S265–S266. 1 indexed citations
11.
Tan, Nguan Soon, Shaun G. Goodman, Raymond T. Yan, et al.. (2014). PROGNOSTIC SIGNIFICANCE OF LOW QRS VOLTAGE ON THE ADMISSION ELECTROCARDIOGRAM IN ACUTE CORONARY SYNDROMES. Canadian Journal of Cardiology. 30(10). S60–S60. 2 indexed citations
12.
McLaughlin, Vallerie V., A. Langer, Alice Dragomir, et al.. (2009). Treatment of Pulmonary Arterial Hypertension (PAH): Data from the Quality Enhancement Research Initiative.. A1043–A1043. 1 indexed citations
13.
Gupta, Madhu, Eduardo de Teresa, Csaba Farsang, et al.. (2007). PO23-732 LDL-C AND CRP LOWERING WITH ATORVASTATIN IN SOUTH ASIANS AND CAUCASIANS: INSIGHTS FROM THE ACTFAST STUDY. Atherosclerosis Supplements. 8(1). 195–195. 1 indexed citations
14.
Goodman, Shaun G., Iqbal Bata, Albert Fung, et al.. (1996). PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.. PubMed. 12(11). 1183–90. 3 indexed citations
15.
Langer, A., et al.. (1995). Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in unstable angina patients.. PubMed. 11(2). 117–22. 13 indexed citations
16.
Krucoff, Mitchell W., A. Langer, Sharon Sawchak, et al.. (1993). Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.. PubMed. 26 Suppl. 249–55. 5 indexed citations
17.
Langer, A., et al.. (1976). Treatment of urinary stress incontinence. Use of dermal graft in the sling procedure.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 47(3). 377–9. 11 indexed citations
18.
Langer, A.. (1976). Oral signs of aging and their clinical significance.. PubMed. 31(12). 63–9. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Joussain Breakdown of academic impact, for papers by Wan-Chun Liao Breakdown of academic impact, for papers by Christina‐Anastasia Rapidi Breakdown of academic impact, for papers by Susanna Lavezzi Breakdown of academic impact, for papers by Halil Önder Breakdown of academic impact, for papers by Gyu Sik Kim Breakdown of academic impact, for papers by Masafumi Nakagawa Breakdown of academic impact, for papers by Jørgen Jørgensen Breakdown of academic impact, for papers by Heeyoune Jung
Rankless by CCL
2026